Edition:
India

Jubilant Life Sciences Ltd (JULS.BO)

JULS.BO on Bombay Stock Exchange

714.10INR
12:04pm IST
Change (% chg)

Rs9.80 (+1.39%)
Prev Close
Rs704.30
Open
Rs705.00
Day's High
Rs724.80
Day's Low
Rs705.00
Volume
56,267
Avg. Vol
150,560
52-wk High
Rs765.00
52-wk Low
Rs287.20

Select another date:

Tue, Feb 7 2017

BRIEF-Jubilant Life Sciences approves purchase of 1.87 bln rupees worth preference shares of Jubilant Biosys

* Approved acquisition of optionally convertible redeemable preference shares of Jubilant Biosys aggregating to 1.87 billion rupees Source text: http://bit.ly/2kIuKId Further company coverage:

BRIEF-Jubilant Life Sciences issues NCDs worth 4.95 bln rupees

* Jubilant Life Sciences issues NCDs worth 4.95 billion rupees Source text: (http://bit.ly/2jwwMtL) Further company coverage:

BRIEF-Jubilant Life Sciences seeks members' nod for issue of NCDs worth up to 10 bln rupees

* Seeks members' nod for issue of non-convertible debentures worth up to 10 billion rupees Source text: http://bit.ly/2gmAC4b Further company coverage:

BRIEF-Indo Borax & Chemicals restarts production activity from Pithampur plant

* Restarted production activity from Pithampur plant from November 10, 2016. Source text: http://bit.ly/2fHAImr Further company coverage:

BRIEF-Jubilant Life Sciences announces commercial paper issue of 500 mln rupees

* Says issuance of commercial papers of 500 million rupees Source text: http://bit.ly/2fCg3lh Further company coverage:

BRIEF-Jubilant Life Sciences gets FDA nod for generic version of Crestor drug

* Says Jubilant Life Sciences receives ANDA approval for rosuvastatin calcium tablets Source text: http://bit.ly/2f8kxjy Further company coverage: (Bengaluru newsroom)

BRIEF-Jubilant Life Sciences Sept-qtr consol profit up about 15 pct

* Net profit in sept quarter last year was 1.26 billion rupees as per Ind-AS; net sales was 14.74 billion rupees Source text (http://bit.ly/2eymiYy) Further company coverage: (Bengaluru newsroom)

BRIEF-Jubilant Life Sciences to consider issue of NCDs worth 10 bln rupees

* To consider the proposal to issue non-convertible debentures up to an amount of 1,000 crore rupees Source text: http://bit.ly/2eD8Wsp Further company coverage:

BRIEF-Jubilant Life Sciences issues commercial paper worth up to 500 mln rupees

* Jubilant Life Sciences says issuance of commercial paper of an aggregate amount of 500 million rupees Source text: http://bit.ly/2dbtSJd Further company coverage: (Bengaluru newsroom)

BRIEF-Jubilant Life Sciences gets ANDA approval for Darifenacin ER tablets

* Says Jubilant Life Sciences receives ANDA approval for Darifenacin ER tablets Source text: http://bit.ly/2dMoFFv Further company coverage: (Bengaluru newsroom)

Select another date:

More From Around the Web